Thesla Palanee to Humans
This is a "connection" page, showing publications Thesla Palanee has written about Humans.
Connection Strength
0,074
-
Cytotoxicity of aflatoxin B1 and its chemically synthesised epoxide derivative on the A549 human epithelioid lung cell line. Mycopathologia. 2001; 151(3):155-9.
Score: 0,014
-
An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women. J Acquir Immune Defic Syndr. 2016 07 01; 72(3):333-43.
Score: 0,010
-
Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015 Feb 05; 372(6):509-18.
Score: 0,009
-
Enrollment of adolescents aged 16-17 years old in microbicide trials: an evidence-based approach. J Adolesc Health. 2014 Jun; 54(6):654-62.
Score: 0,009
-
Hidden harms: women's narratives of intimate partner violence in a microbicide trial, South Africa. Soc Sci Med. 2014 Jun; 110:49-55.
Score: 0,009
-
Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel. AIDS Behav. 2011 Feb; 15(2):407-21.
Score: 0,007
-
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010 Oct 16; 376(9749):1329-37.
Score: 0,007
-
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008 Dec 06; 372(9654):1977-87.
Score: 0,006
-
MDR1 and CYP3A4 polymorphisms among African, Indian, and white populations in KwaZulu-Natal, South Africa. Clin Pharmacol Ther. 2003 Aug; 74(2):195-6.
Score: 0,004